How many drugs treat Community-acquired pneumonia?

Drug Landscape tracks 5 marketed treatments for Community-acquired pneumonia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/community-acquired-pneumonia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Community-acquired pneumonia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Community-acquired pneumonia (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Community-acquired pneumonia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Test formulation (Treatment A)	test-formulation-treatment-a	Pfizer	Enzyme inhibitor	Specific enzyme	Not yet determined
Cefpodoxime Proxetil	CEFPODOXIME	Pfizer			2007-01-01
Invanz	ERTAPENEM	Merck & Co.	Penem Antibacterial		2001-01-01
Piperacillin And Tazobactam	Piperacillin Sodium	Pfizer	Penicillin-class antibacterial with beta-lactamase inhibitor	Bacterial cell wall; beta-lactamase enzyme	1981-01-01
Zithromax	Azithromycin	Pfizer Inc.	Macrolide	Not specified in label

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 3 drugs in Community-acquired pneumonia
· 1 drug in Community-acquired pneumonia
Merck & Co. · 1 drug in Community-acquired pneumonia
Pfizer Inc. · 1 drug in Community-acquired pneumonia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Community-acquired pneumonia:

Cite this brief

Drug Landscape (2026). Community-acquired pneumonia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/community-acquired-pneumonia. Accessed 2026-06-09.

Community-acquired pneumonia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing